CELCUITY INC. Operating Expenses
CELCUITY INC. (CELC) reported Operating Expenses of $66.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- CELCUITY INC. operating expenses for the quarter ending 2026-06-30 was $66.12M, a 50.24% increase year-over-year.
- CELCUITY INC. operating expenses for the quarter ending 2026-03-31 was $50.51M, a 39.78% increase year-over-year.
- CELCUITY INC. operating expenses for the quarter ending 2025-12-31 was $49.20M, a 35.06% increase year-over-year.
- CELCUITY INC. operating expenses for the quarter ending 2025-09-30 was $42.85M, a 42.54% increase year-over-year.
- CELCUITY INC. operating expenses for fiscal 2025 was $172.19M, a 52.02% increase from fiscal 2024.
- CELCUITY INC. operating expenses for fiscal 2024 was $113.27M, a 71.02% increase from fiscal 2023.
- CELCUITY INC. operating expenses for fiscal 2023 was $66.23M, a 68.14% increase from fiscal 2022.
- CELCUITY INC. operating expenses for fiscal 2022 was $39.39M, a 38.92% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $66.12M 10-Q · filed 2026-08-13 | $116.63M 10-Q · filed 2026-08-13 | $165.83M derived: sum of 3 quarters · filed 2026-08-13 | $208.68M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $50.51M 10-Q · filed 2026-05-14 | $99.71M derived: sum of 2 quarters · filed 2026-05-14 | $142.56M derived: sum of 3 quarters · filed 2026-05-14 | $186.57M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $49.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $92.05M derived: sum of 2 quarters · filed 2026-03-26 | $136.06M derived: sum of 3 quarters · filed 2026-08-13 | $172.19M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $42.85M 10-Q · filed 2025-11-13 | $86.86M derived: sum of 2 quarters · filed 2026-08-13 | $122.99M 10-Q · filed 2025-11-13 | $159.42M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $44.01M 10-Q · filed 2026-08-13 | $80.14M 10-Q · filed 2026-08-13 | $116.57M derived: sum of 3 quarters · filed 2026-08-13 | $146.63M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $36.13M 10-Q · filed 2026-05-14 | $72.56M derived: sum of 2 quarters · filed 2026-05-14 | $102.62M derived: sum of 3 quarters · filed 2026-05-14 | $126.91M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $36.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $66.49M derived: sum of 2 quarters · filed 2026-03-26 | $90.77M derived: sum of 3 quarters · filed 2026-03-26 | $113.27M 10-K · filed 2026-03-26 | $113.27M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $30.06M 10-Q · filed 2025-11-13 | $30.06M 10-Q · filed 2024-11-14 | $54.34M derived: sum of 2 quarters · filed 2025-11-13 | $76.84M 10-Q · filed 2025-11-13 | $76.84M 10-Q · filed 2024-11-14 | $96.57M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $24.28M 10-Q · filed 2025-08-14 | $24.28M 10-Q · filed 2024-08-14 | $46.78M 10-Q · filed 2025-08-14 | $46.78M 10-Q · filed 2024-08-14 | $66.51M derived: sum of 3 quarters · filed 2025-08-14 | $85.40M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $22.49M 10-Q · filed 2025-05-15 | $22.49M 10-Q · filed 2024-05-15 | $42.22M derived: sum of 2 quarters · filed 2025-05-15 | $61.12M derived: sum of 3 quarters · filed 2025-05-15 | $76.18M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $19.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $38.63M derived: sum of 2 quarters · filed 2025-03-31 | $53.68M derived: sum of 3 quarters · filed 2025-03-31 | $66.23M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $18.90M 10-Q · filed 2024-11-14 | $33.95M derived: sum of 2 quarters · filed 2024-11-14 | $46.50M 10-Q · filed 2024-11-14 | $58.14M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $15.06M 10-Q · filed 2024-08-14 | $27.60M 10-Q · filed 2024-08-14 | $39.24M derived: sum of 3 quarters · filed 2024-08-14 | $49.89M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $12.55M 10-Q · filed 2024-05-15 | $24.19M derived: sum of 2 quarters · filed 2024-05-15 | $34.83M derived: sum of 3 quarters · filed 2024-05-15 | $44.43M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $22.28M derived: sum of 2 quarters · filed 2024-03-27 | $31.88M derived: sum of 3 quarters · filed 2024-03-27 | $39.39M 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | $10.64M 10-Q · filed 2023-11-13 | $20.24M derived: sum of 2 quarters · filed 2023-11-13 | $27.75M 10-Q · filed 2023-11-13 | $34.07M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $9.60M 10-Q · filed 2023-08-11 | $17.11M 10-Q · filed 2023-08-11 | $23.43M derived: sum of 3 quarters · filed 2023-08-11 | $29.03M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | $7.51M 10-Q · filed 2023-05-15 | $13.83M derived: sum of 2 quarters · filed 2023-05-15 | $19.43M derived: sum of 3 quarters · filed 2023-05-15 | $33.07M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $6.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $11.92M derived: sum of 2 quarters · filed 2023-03-23 | $25.56M derived: sum of 3 quarters · filed 2023-03-23 | $28.36M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $5.60M 10-Q · filed 2022-11-10 | $19.24M derived: sum of 2 quarters · filed 2022-11-10 | $22.04M 10-Q · filed 2022-11-10 | $24.59M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $13.64M 10-Q · filed 2022-08-12 | $16.44M 10-Q · filed 2022-08-12 | $18.99M derived: sum of 3 quarters · filed 2022-08-12 | $21.47M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $2.79M 10-Q · filed 2022-05-16 | $5.34M derived: sum of 2 quarters · filed 2022-05-16 | $7.82M derived: sum of 3 quarters · filed 2022-05-16 | $10.04M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $5.03M derived: sum of 2 quarters · filed 2022-03-23 | $7.25M derived: sum of 3 quarters · filed 2022-03-23 | $9.56M 10-K · filed 2022-03-23 | ||||
| 2020-09-30 | $2.48M 10-Q · filed 2021-11-09 | $4.69M derived: sum of 2 quarters · filed 2021-11-09 | $7.00M 10-Q · filed 2021-11-09 | $8.90M derived: sum of 4 quarters · filed 2021-11-09 | ||||
| 2020-06-30 | $2.21M 10-Q · filed 2021-08-11 | $4.52M 10-Q · filed 2021-08-11 | $6.42M derived: sum of 3 quarters · filed 2021-08-11 | $8.51M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $2.31M 10-Q · filed 2021-05-10 | $4.21M derived: sum of 2 quarters · filed 2021-05-10 | $6.30M derived: sum of 3 quarters · filed 2021-05-10 | $8.14M derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $3.99M derived: sum of 2 quarters · filed 2021-02-16 | $5.83M derived: sum of 3 quarters · filed 2021-02-16 | $7.81M 10-K · filed 2021-02-16 | ||||
| 2019-09-30 | $2.09M 10-Q · filed 2020-11-09 | $3.93M derived: sum of 2 quarters · filed 2020-11-09 | $5.91M 10-Q · filed 2020-11-09 | $7.86M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $1.84M 10-Q/A · filed 2020-08-11 | $3.82M 10-Q/A · filed 2020-08-11 | $5.77M derived: sum of 3 quarters · filed 2020-08-11 | $7.74M derived: sum of 4 quarters · filed 2020-08-11 | ||||
| 2019-03-31 | $1.97M 10-Q · filed 2020-05-07 | $3.93M derived: sum of 2 quarters · filed 2020-05-07 | $5.90M derived: sum of 3 quarters · filed 2020-05-07 | $7.83M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $3.93M derived: sum of 2 quarters · filed 2020-03-13 | $5.86M derived: sum of 3 quarters · filed 2020-03-13 | $7.93M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $1.98M 10-Q · filed 2019-11-07 | $3.91M derived: sum of 2 quarters · filed 2019-11-07 | $5.98M 10-Q · filed 2019-11-07 | $7.81M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $1.93M 10-Q · filed 2019-08-08 | $4.01M 10-Q · filed 2019-08-08 | $5.83M derived: sum of 3 quarters · filed 2019-08-08 | $7.36M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $2.08M 10-Q · filed 2019-05-07 | $3.90M derived: sum of 2 quarters · filed 2019-05-07 | $5.43M derived: sum of 3 quarters · filed 2019-05-07 | $7.04M derived: sum of 4 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $3.35M derived: sum of 2 quarters · filed 2019-03-01 | $4.96M derived: sum of 3 quarters · filed 2019-03-01 | $5.95M 10-K · filed 2019-03-01 | ||||
| 2017-09-30 | $1.53M 10-Q · filed 2018-11-13 | $3.14M derived: sum of 2 quarters · filed 2018-11-13 | $4.13M 10-Q · filed 2018-11-13 | $5.04M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $1.61M 10-Q · filed 2018-08-09 | $2.60M 10-Q · filed 2018-08-09 | $3.51M derived: sum of 3 quarters · filed 2018-08-09 | $4.38M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $993.91K 10-Q · filed 2018-05-14 | $1.90M derived: sum of 2 quarters · filed 2018-05-14 | $2.78M derived: sum of 3 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | $907.41K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.78M derived: sum of 2 quarters · filed 2018-03-15 | $3.33M 10-K · filed 2018-03-15 | |||||
| 2016-09-30 | $877.54K 10-Q · filed 2017-12-01 | $2.42M 10-Q · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |